Borenstein Todd, Gonzalez Tyler, Krevolin Janet, Den Hartog Bryan, Thordarson David
Department of Orthopedics, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Bio2 Technologies, Woburn, MA, USA.
Foot Ankle Orthop. 2023 Aug 29;8(3):24730114231195358. doi: 10.1177/24730114231195358. eCollection 2023 Jul.
Medial cuneiform dorsal opening wedge (Cotton) osteotomy is often used for treating forefoot varus in patients undergoing surgery for stage II posterior tibialis tendon dysfunction. The goal of this study was to examine the radiographic outcomes of Cotton osteotomy with bioactive glass wedge to assess for both maintenance of correction and clinical results and complications. We hypothesized that bioactive glass wedges would maintain correction of the osteotomy with low complication rates.
Between December 2015 and June 2016, the charts of 17 patients (10 female and 7 male) who underwent Cotton osteotomy using bioactive glass wedges were retrospectively reviewed. Patient age averaged 56.8 years (range, 16-84). The average follow-up was 6.5 months. Radiographs were reviewed to assess for initial correction and maintenance of correction of medial column sag as well as for union. Charts were reviewed for complications.
The medial column sag correction averaged 15.6% on the final postoperative lateral radiograph. Meary angle averaged 19 degrees (3.14-42.8 degrees) preoperatively and 5.5 degrees (0.4-20.7 degrees) at final follow-up. All patients achieved clinical and radiographic union. One patient developed neuropathic midfoot pain and was managed with sympathetic blocks. One patient had a delayed union that healed at 6 months without surgical intervention. No patients required the use of custom orthotics or subsequent surgical procedures.
Cotton osteotomy with bioactive glass wedges produced consistent correction of the medial column with low risk.
Level IV, case series.
内侧楔骨背侧开放楔形(科顿)截骨术常用于治疗Ⅱ期胫后肌腱功能障碍患者的前足内翻。本研究的目的是检查使用生物活性玻璃楔形物进行科顿截骨术的影像学结果,以评估矫正的维持情况、临床结果及并发症。我们假设生物活性玻璃楔形物能以低并发症发生率维持截骨术的矫正效果。
回顾性分析2015年12月至2016年6月间17例行使用生物活性玻璃楔形物的科顿截骨术患者(10例女性,7例男性)的病历。患者平均年龄56.8岁(范围16 - 84岁)。平均随访6.5个月。复查X线片以评估内侧柱矢状面的初始矫正及维持情况以及愈合情况。查阅病历以了解并发症情况。
术后最终的侧位X线片上,内侧柱矢状面矫正平均为15.6%。术前Meary角平均为19度(3.14 - 42.8度),末次随访时为5.5度(0.4 - 20.7度)。所有患者均实现临床及影像学愈合。1例患者出现神经性中足疼痛,通过交感神经阻滞治疗。1例患者出现延迟愈合,6个月时未行手术干预自行愈合。无患者需要使用定制矫形器或后续手术治疗。
使用生物活性玻璃楔形物的科顿截骨术能在内侧柱产生持续一致的矫正效果,且风险较低。
IV级,病例系列。